Clinical Trials Sponsored by Agendia

Total 124 results

Agendia

Completed

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score (PROMIS)

Hormone Receptor Positive Malignant Neoplasm of Breast

United States
Agendia

Unknown

A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint (PARSC)

Colon Cancer

United States, Netherlands, Austria, Denmark, Germany, United Kingdom, Switzerland, China, France, Japan, Spain, Sweden
Agendia

Completed

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry (IMPACt)

Breast Cancer

United States
Agendia

Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles (FLEX)

Breast Cancer

United States, Israel, Greece
Agendia

Completed

NBRST: Prospective Neo-adjuvant REGISTRY Trial (NBRST)

Breast Cancer

United States
Agendia

Completed

The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients

Chinese

United States
UNICANCER
Agendia

Recruiting

Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk (LESS)

Breast Cancer

France
Diakonessenhuis, Utrecht
Agendia

Completed

The Symphony Triple A Study: Using Symphony in Treatment Decisions Concerning Adjuvant Systemic Therapy (Symphony)

Breastcancer | Invasive Breast Carcinoma by Gene Expression Profile

Netherlands
Johns Hopkins University
Agendia

Completed

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer

Breast Cancer

United States
West German Study Group
Agendia

Completed

PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe) (PRIMe)

Breast Cancer

Switzerland, Austria, Germany
Agennix

Completed

Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen

Prostate Cancer | Hormone Refractory Prostate Cancer

United States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
Agennix

Terminated

Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies

Malignancies

United States
West German Study Group
Agendia

Recruiting

PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS (PROOFS)

Female Breast Cancer

Germany
Agendia
Osaka General Medical Center

Completed

Validation of 70-gene MammaPrint Profile in Japanese Population

Breast Cancer

Japan
Agennix

Terminated

Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) (SPERA)

Prostate Cancer

United States
Agennix

Completed

Satraplatin for Patients With Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer

United States
Agennix

Terminated

Study of Satraplatin (JM-216) in Combination With Docetaxel

Tumors

United States
Agennix

Unknown

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer (FORTIS-C)

Non Small Cell Lung Cancer

United States
Agennix

Completed

Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis

Severe Sepsis

United States, Canada, France, Germany, Spain
Agennix

Completed

Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma

Carcinoma, Renal Cell

United States
Agennix

Completed

Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer (FORTIS-M)

Non Small Cell Lung Cancer

United States, Spain, France, Canada, Bulgaria, Australia, Russian Federation, Turkey, Taiwan, Hungary, Philippines, Czech Republic, Germany, Greece, India, Italy, Korea, Republic of, Latvia, Malaysia, Poland, Romania, Singapore, United...
Agennix

Terminated

Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy

Lung Cancer | Carcinoma, Non-small Cell Lung

United States
Agennix

Completed

A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)

Lung Cancer

United States, Canada, Chile
Agennix

Withdrawn

Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies

Hematological Malignancies
Agennix

Terminated

A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel

Prostate Cancer | Tumors

United States
Agennix

Completed

Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
Agennix

Terminated

A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence

Prostate Cancer

United States
Agennix

Suspended

Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis (OASIS)

Severe Sepsis

United States, Spain, Belgium, France, United Kingdom, Canada, Israel, Germany, Denmark, Netherlands
Agenzia Regionale emergenza Urgenza

Recruiting

Enhancing Prehospital Stroke Diagnosis (AIPO)

Stroke

Italy
Agenzia Regionale Sanitaria delle Marche

Completed

Experimental Prospective Study on the Effectiveness and Efficiency of the Implementation of Clinical Pathways (EPSEEIC2004)

Congestive Heart Failure
Nova Argentia S.r.l.

Recruiting

Study to Evaluate the Effectiveness of a Medical Device Based on Hyaluronic Acid in Wounds (WOUND-H)

Wound Healing Disorder

Italy
Yale University
Agennix

Completed

Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers

Advanced Cancers

United States
S. Andrea Hospital
Agenzia Italiana del Farmaco

Completed

Efficacy of Riluzole in Hereditary Cerebellar Ataxia

Cerebellar Ataxia

Italy
Universidad de Córdoba
Agencia Estatal de Investigación

Active, not recruiting

Cost-benefit Evaluation of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care (PsicAP-Costs)

Depression | Anxiety Disorders | Somatoform Disorders | Emotional Disorder

Spain
Federico II University
Agenzia Italiana del Farmaco

Completed

Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study (stayondiur)

Essential Hypertension

Italy
Istituto Clinico Humanitas
Agenzia Italiana del Farmaco

Unknown

Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis (SCILLA)

Colitis, Ulcerative

Italy
University of Bologna
Agenzia Italiana del Farmaco

Completed

Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis (ANSWER)

Liver Cirrhosis | Ascites

Italy
San Gerardo Hospital
Agenzia Italiana del Farmaco

Completed

Standardized Educational Plan for Epilepsy Patients With Comorbidities (EDU-COM)

Epilepsy

Italy
European Institute of Oncology
Agenzia Italiana del Farmaco

Recruiting

Neoadjuvant PRRT With Y-90-DOTATOC in pNET (NeoNet)

Pancreatic Neuroendocrine Tumor

Italy
IRCCS Policlinico S. Matteo
Agenzia Italiana del Farmaco

Completed

Inhaled GM-CSF Therapy of Autoimmune PAP

Autoimmune Pulmonary Alveolar Proteinosis

Italy
University of Turin, Italy
Agenzia Italiana del Farmaco

Unknown

CPAP Reduces Hypoxemia After Cardiac Surgery (CRHACS)

Acute Respiratory Failure Requiring Reintubation

Italy
IRCCS San Raffaele Roma
Agenzia Italiana del Farmaco

Completed

Levodopa Benserazide Generic Formulation Versus the Originator (FARM9X59Y4)

Parkinson Disease

Italy
University of Milano Bicocca
Agenzia Italiana del Farmaco

Completed

Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS). (HySSAS)

Pulmonary Sarcoidosis

Italy
University of Chile
Agencia Nacional de Investigación y Desarrollo

Not yet recruiting

Optimal Therapeutic Dose of tDCS for Functional Upper Limb Recovery in People With Stroke

Stroke | Neurologic Deficits
University of Chile
Agencia Nacional de Investigación y Desarrollo

Recruiting

Endothelial Dysfunction and Non-cardiac Surgery

Stroke | Myocardial Injury | Surgery | Cardiac Death

Chile
Azienda Ospedaliera Universitaria Integrata Verona
Agenzia Italiana del Farmaco

Unknown

Antibiotic Stewardship Program in Pancreatic Surgery: a Multicenter Time Series Analysis (BIOSTEPS). (BIOSTEPS)

Surgical Site Infection | Antibiotic Resistant Infection

Italy
Giulio Stefanini
Agenzia Italiana del Farmaco

Active, not recruiting

Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines (CONTROL)

Lymphoma, Large B-Cell, Diffuse | Breast Cancer | Chemotherapy Effect | Cardiotoxicity | Left Ventricular Dysfunction

Italy
Agennix
National Institutes of Health (NIH)

Unknown

Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants

Nosocomial Infections

United States
University of Santiago de Compostela
Agencia Estatal de Investigación, Spain

Recruiting

Development and Evaluation of a Psychological Intervention in Videogame Format for the Promotion of Active Aging (GAMEPROAGING)

Aging | Aging Problems

Spain
Vitamin D Study Group
Agencia Nacional de Investigación y Desarrollo

Completed

Cholecalciferol to Improve the Outcomes of COVID-19 Patients (CARED)

COVID

Argentina

Clinical Trials Sponsored by Agendia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations